Edition:
India

Dr. Lal PathLabs Ltd (DLPA.NS)

DLPA.NS on National Stock Exchange of India

905.05INR
9:22am IST
Change (% chg)

Rs-4.85 (-0.53%)
Prev Close
Rs909.90
Open
Rs909.90
Day's High
Rs909.95
Day's Low
Rs905.00
Volume
474
Avg. Vol
80,282
52-wk High
Rs1,125.00
52-wk Low
Rs723.05

Latest Key Developments (Source: Significant Developments)

Dr.Lal Pathlabs Says NCLT Ordered Meetings of Shareholder, Unsecured Creditors For Amalgamation Scheme With Delta Ria And Pathology​​
Friday, 29 Dec 2017 

Dec 29 (Reuters) - Dr. Lal Pathlabs Ltd ::NCLT ORDERED MEETINGS OF SHAREHOLDERS, UNSECURED CREDITORS TO APPROVE SCHEME OF AMALGAMATION BETWEEN CO & DELTA RIA AND PATHOLOGY​.  Full Article

Dr. Lal Pathlabs Says Unit Approves Acquisition Of Satya Pathology And Diagnostic Centre
Tuesday, 12 Dec 2017 

Dec 12 (Reuters) - Dr. Lal Pathlabs Ltd ::SAYS UNIT APPROVES ACQUISITION OF SATYA PATHOLOGY AND DIAGNOSTIC CENTRE.SAYS COST OF ACQUISITION NOT EXCEEDING 20 MILLION RUPEES.  Full Article

India's Dr. Lal Pathlabs Sept-qtr profit falls
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Dr. Lal Pathlabs Ltd ::Sept quarter profit 502 million rupees versus 528 million rupees year ago.Sept quarter revenue from operations 2.69 billion rupees versus 2.53 billion rupees year ago.Declared interim dividend of 1.50 rupees per share.  Full Article

Dr. Lal PathLabs June-qtr profit rises
Friday, 29 Jul 2016 

Dr. Lal PathLabs Ltd : June-quarter net profit 375.5 million rupees versus 287.3 million rupees last year . June-quarter net sales 2.16 billion rupees versus 1.83 billion rupees last year .  Full Article

Dr. Lal PathLabs approves acquisition of Delta Ria and Pathology
Friday, 27 May 2016 

Dr. Lal PathLabs Ltd : Acquisition of Delta ria and pathology private limited . Acquisition of additional 10% stake in paliwal diagnostics private limited and paliwal medicare private limited .  Full Article